Navigation Links
Rockefeller University's Center for Clinical and Translational Science funds pilot studies
Date:1/7/2008

The Rockefeller University Center for Clinical and Translational Science (CCTS) has announced the recipients of its 2008 Pilot Project grants. Eight Rockefeller researchers will each receive $25,000 from the center to fund early studies in translational science that, if successful, might lead to clinical trials. The CCTS and the grant program are in their second year, established through funds from a Clinical and Translational Science Award the university received from the National Center for Research Resources of the National Institutes of Health. In its first year, the program provided $165,000 for nine clinical studies.

The centers administration selected the 2008 pilot projects from among proposals submitted in the fall. The recipients are:

  • Marina Caskey, an instructor in clinical investigation, to compare the efficacy of poly IC and Ampligen as adjuvants for an HIV vaccine targeted at DEC-205, an antigen receptor on dendritic cells.

  • Delivette Castor, instructor in clinical investigation, to apply demographic, psychosocial, sexual and drug use history and other data gathered from 280 men who have sex with men to examine the roles of these factors in the risk of HIV-1 infection and transmitted drug resistance.

  • Mouquet Hugo, postdoctoral fellow in Michel Nussenzweigs Laboratory of Molecular Immunology, to elucidate the etiology of Pemphigus vulgaris, a life-threatening autoimmune disease affecting skin and mucosa, by comparing repertoires of autoreactive and polyreactive B cells in patients with the disease to those of healthy volunteers.

  • Igor Kravets, instructor in clinical investigation, to examine the mechanism of action of disulfiram, a drug commonly used to treat chronic alcoholism, with regard to cocaine addiction.

  • Jan Lunemann, postdoctoral fellow in Christian Mnzs Laboratory of Viral Immunobiology, to test the hypothesis that a cause of multiple sclerosis is an aberrant response of the central nervous system to the Epstein Barr virus on the level of virus-infected B cells.

  • Lisa Neff, instructor in clinical investigation, to test the hypothesis that the Dietary Approaches to Stop Hypertension diet and the low glycemic index diet improve insulin sensitivity in patients with insulin resistance and/or metabolic syndrome.

  • Swaroop Pendyala, instructor in clinical investigation, to determine if significant weight loss achieved by dieting decreases chronic inflammation in the colorectal epithelium and reduces fecal calprotectin levels.

  • Alexander Ploss, postdoctoral associate in Charles Rices Laboratory of Virology and Infectious Disease, to generate patient-specific human hepatocytes as a renewable source for primary liver tissue.


'/>"/>

Contact: Joseph Bonner
bonnerj@rockefeller.edu
212-327-8998
Rockefeller University
Source:Eurekalert

Related medicine news :

1. National Patient Advocate Foundation Hails Senator Rockefeller for Introducing Bill Protecting Patient Access to Health Coverage
2. Columbia Center for Childrens Environmental Health receives NIEHS grant to study asthma
3. Parkway Clinical Laboratories Expands Management Team to Support a National Growth Strategy Centered on Oral Fluid Drug Screening
4. Susan G. Komen for the Cure, Ryan Community Health Centers, Breast Cancer Survivors Call on New York State to Expand Breast Cancer Screening, Treatment Programs
5. Language centers revealed, brain surgery refined with new mapping
6. Brown named Center of Excellence in Geriatric Medicine and Training
7. American College of Physicians receives grant to study cost of patient-centered medical home
8. Americas Blood Centers Thanks Donors During Celebration of National Blood Donor Month
9. Grubb & Ellis Healthcare REIT Acquires Chesterfield Rehabilitation Center in Chesterfield, Missouri in a Joint Venture with Duke Realty
10. Fitworks West Chester Mega-Center Now Open
11. National Drug Intelligence Center Releases 2008 National Methamphetamine Threat Assessment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology: